高级检索
当前位置: 首页 > 详情页

A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China [2]Department of Hepatology, GuangdongProvincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China [3]Department of Radiology, the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China [4]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China [5]Departmentof Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China [6]Section of Endocrinology, Diabetes and Metabolism,Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy [7]Southampton National Institute forHealth Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK [8]Departmentof Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China [9]Institute of Hepatology, Wenzhou Medical University,Wenzhou, China [10]Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou,China
出处:
ISSN:

关键词: Nonalcoholic fatty liver disease (NAFLD) inflammation activity radiomics magnetic resonance imaging (MRI)

摘要:
Background: Currently, there are no effective methods for assessing hepatic inflammation without resorting to histological examination of liver tissue obtained by biopsy. T2-weighted images (T2WI) are routinely obtained from liver magnetic resonance imaging (MRI) scan sequences. We aimed to establish a radiomics signature based on T2WI (T2-RS) for assessment of hepatic inflammation in people with nonalcoholic fatty liver disease (NAFLD). Methods: A total of 203 individuals with biopsy-confirmed NAFLD from two independent Chinese cohorts with liver MRI examination were enrolled in this study. The hepatic inflammatory activity score (IAS) was calculated by the unweighted sum of the histologic scores for lobular inflammation and ballooning. One thousand and thirty-two radiomics features were extracted from the localized region of interest (ROI) in the right liver lobe of T2WI and, subsequently, selected by minimum redundancy maximum relevance and least absolute shrinkage and selection operator (LASSO) methods. The T2-RS was calculated by adding the selected features weighted by their coefficients. Results: Eighteen radiomics features from Laplacian of Gaussian, wavelet, and original images were selected for establishing T2-RS. The T2-RS value differed significantly between groups with increasing grades of hepatic inflammation (P<0.01). The T2-RS yielded an area under the receiver operating characteristic (ROC) curve (AUROC) of 0.80 [95% confidence interval (CI): 0.71-0.89] for predicting hepatic inflammation in the training cohort with excellent calibration. The AUROCs of T2-RS in the internal cohort and external validation cohorts were 0.77 (0.61-0.93) and 0.75 (0.63-0.84), respectively. Conclusions: The T2-RS derived from radiomics analysis of T2WI shows promising utility for predicting hepatic inflammation in individuals with NAFLD.

基金:

基金编号: 82070588 S2032102600032 IS-BRC-20004

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 1 区 营养学 1 区 外科 2 区 胃肠肝病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学 1 区 营养学 1 区 外科
JCR分区:
出版当年[2020]版:
Q1 SURGERY Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 NUTRITION & DIETETICS
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 NUTRITION & DIETETICS Q1 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
共同第一作者:
通讯作者:
通讯机构: [2]Department of Hepatology, GuangdongProvincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China [4]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China [9]Institute of Hepatology, Wenzhou Medical University,Wenzhou, China [10]Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou,China [*1]NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University No. 2 Fuxue Lane, Wenzhou 325000, China [*2]Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号